Caspase-2 Inhibitor Z-VDVAD-FMK

Caspase-2 Inhibitor Z-VDVAD-FMK is a synthetic pentapeptide-based compound designed to selectively inhibit caspase-2, a cysteine protease implicated in the regulation of apoptosis and cellular stress responses. As an irreversible inhibitor, Z-VDVAD-FMK covalently modifies the active site of caspase-2, effectively blocking its enzymatic activity. This molecular tool has gained prominence in cell biology and biochemical research for its ability to dissect the specific roles of caspase-2 in programmed cell death and non-apoptotic cellular pathways. Its application extends to the elucidation of signaling mechanisms, investigation of protease cascades, and the validation of caspase-2 as a target in various experimental models.

Apoptosis research: Z-VDVAD-FMK is widely employed in studies aiming to clarify the role of caspase-2 in apoptosis. By providing targeted inhibition, the compound enables researchers to distinguish caspase-2-dependent apoptotic pathways from those mediated by other caspases. This selectivity facilitates the mapping of mitochondrial and extrinsic death signaling events, allowing for precise delineation of caspase-2's contribution to cellular fate decisions in response to genotoxic stress, oxidative injury, or developmental cues.

Protease signaling pathway analysis: In the context of protease cascade mapping, Z-VDVAD-FMK serves as a critical tool to interrupt caspase-2 activity and analyze downstream effects on substrate cleavage and signal transduction. Application of this inhibitor helps delineate the hierarchical organization of caspase activation, revealing substrate specificity and cross-talk between caspase-2 and other family members. These insights are essential for constructing accurate models of cell death and survival signaling networks.

Cellular stress and DNA damage studies: Caspase-2 has been implicated in cellular responses to DNA damage, metabolic imbalance, and oxidative stress. Utilizing Z-VDVAD-FMK, researchers can selectively suppress caspase-2-mediated signaling events, thereby investigating its role in cell cycle regulation, checkpoint control, and stress-induced apoptosis. The inhibitor's utility in these experimental paradigms provides mechanistic understanding of how cells respond to genotoxic insults and maintain genomic integrity.

Functional proteomics: The specificity and irreversible binding of Z-VDVAD-FMK make it suitable for functional proteomics applications. By employing the inhibitor in proteome-wide studies, investigators can identify caspase-2 substrates and interacting partners under various physiological and experimental conditions. This approach supports the discovery of novel protein targets and regulatory mechanisms associated with caspase-2 activity, advancing the broader field of protease biology.

Drug discovery and target validation: In the early stages of drug development, Z-VDVAD-FMK is often incorporated into screening assays to validate caspase-2 as a molecular target. By selectively inhibiting this protease in cellular or biochemical models, researchers can assess the functional consequences of caspase-2 blockade and evaluate the therapeutic potential of candidate compounds. This application is fundamental for advancing the understanding of caspase-2's role in disease mechanisms and for guiding the rational design of new modulators targeting apoptotic and stress response pathways.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats